Ticker Details
Pacific Biosciences of California, Inc. Pacific Biosciences of California Inc is a biotechnology company. It is engaged in design, development, and manufacture of sequencing system to help scientists resolve genetically complex problems.
IPO Date:	October 27, 2010
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$407.7M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.24 | 3.26%
Avg Daily Range (30 D):	$0.05 | 3.25%
Avg Daily Range (90 D):	$0.07 | 3.66%

Institutional Daily Volume
Avg Daily Volume:	2.75M
Avg Daily Volume (30 D):	5.34M
Avg Daily Volume (90 D):	6.27M

Trade Size
Avg Trade Size (Sh.):	202
Avg Trade Size (Sh.) (30 D):	379
Avg Trade Size (Sh.) (90 D):	373

Institutional Trades
Total Institutional Trades:	4,417
Avg Institutional Trade:	$2.16M
Avg Institutional Trade (30 D):	$.88M
Avg Institutional Trade (90 D):	$.94M
Avg Institutional Trade Volume:	.23M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.27M
Avg Closing Trade (30 D):	$.88M
Avg Closing Trade (90 D):	$.97M
Avg Closing Volume:	346.13K

News

Apr 7, 2026 @ 5:44 PM Global DNA Read, Write and Edit Market to Surge to... Source: Bcc Research

Oct 31, 2025 @ 7:15 AM Genomics Data Analysis Market Size to Surpass USD ... Source: Nova One Advisor

Aug 6, 2025 @ 1:00 PM PacBio to Present at Upcoming Investor Conferences... Source: Pacbio

Jun 21, 2025 @ 12:00 PM Long Read Sequencing Market Projected to Reach USD... Source: Sns Insider

May 14, 2025 @ 8:30 AM Metagenomics Market Size, Share, Forecast & Trends... Source: Researchandmarkets.Com

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.82	$-.13	$-1.82
Diluted EPS	$-1.82	$-.13	$-1.82
Revenue	$160.01M	$44.65M	$160.01M
Gross Profit	$45.78M	$16.57M	$45.78M
Net Income / Loss	$-546.38M	$-40.37M	$-546.38M
Operating Income / Loss	$-553.86M	$-41.2M	$-553.86M
Cost of Revenue	$114.23M	$28.08M	$114.23M
Net Cash Flow	$7.67M	$6.96M	$7.67M
PE Ratio